Michelle Zingone Farland, PharmD, BCPS, CDE
1924 Alcoa Highway, Room 210
Ambulatory Care Pharmacy Residency, Virginia Commonwealth University
Pharmacy Practice Residency, Shands Jacksonville
Pharm.D., University of Pittsburgh School of Pharmacy
2013 University of Pittsburgh Alumni Society Rising Star Award
2012 American College of Clinical Pharmacy New Educator Award
2011 Phi Lambda Sigma Theta Chapter Alumna of the Year Award
2006 Florida Society of Health-System Pharmacists Research Award
2007 - 2014 Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties
2008 - 2018 Certified Diabetes Educator, National Certification Board for Diabetes Educators
2012 American Pharmacists Association, Delivering Medication Therapy Management Services Faculty Trainer
Michelle Farland is an Associate Professor in the Department of Clinical Pharmacy at the University of Tennessee Health Science Center College of Pharmacy. Dr. Farland’s clinical practice, teaching, and research site is in Primary Care at the University of Tennessee Medical Center in Knoxville. She is a board certified pharmacotherapy specialist and certified diabetes educator. She serves as a reviewer for several pharmacy journals and is on the editorial board for The Annals of Pharmacotherapy. Dr. Farland teaches throughout the Doctor of Pharmacy curriculum with a focus in Medication Therapy Management and chronic disease state management. Dr. Farland’s research focuses on the impact of pharmacist involvement in an interdisciplinary care setting on patient outcomes of chronic diseases and educational outcomes of incorporating team-based learning in the Doctor of Pharmacy curriculum.
1. Farland, MZ, Sicat BL, Franks AS, Pater KS, Medina MS, Persky AM. Best practices for implementing team-based learning in pharmacy education. Am J Pharm Educ. (in press)
2. Farland MZ, Byrd DC, McFarland MS, Thomas J, Franks AS, George CM, Gross B, Guirguis AB, Suda KJ. Pharmacist-physician collaboration for diabetes care: the diabetes initiative program. Ann Pharmacother, 2013;47:781-9.
3. Farland MZ, Peters CJ, Williams JD, Bielak KM, Heidel RE, Ray SM. Beta-blocker use and incidence of chronic obstructive pulmonary disease exacerbations. Ann Pharmacother, 2013;47:651-6.
4. Farland MZ, Franks AS, Byrd DC, Thomas JL, Suda KJ. Development of a primary care pharmacist practice based research network. Currents in Pharmacy Teaching and Learning, 4(2), 150-154, 2012.
5. Zingone, MM, Franks, AS, Guirguis, AB, George, CM, Howard-Thompson, A, Heidel, RE. Comparing team-based and mixed active-learning methods in an ambulatory care elective course. Am J Pharm Educ, 74 (9), 160, 2010.
6. Guirguis, AB, Ray, SM, Zingone, MM, Airee, A, Franks, AS, Keenum, AJ. Smoking cessation: barriers to success and readiness to change. Tenn Med, 103 (9), 45-9, 2010.
7. Zingone, MM, Guirguis, AB, Airee, A, Cobb, D. Probable drug interaction between warfarin and hormonal contraceptives. Ann Pharmacother, 43 (12), 2096-102, 2009.
8. Thomas, J, Zingone, MM, Smith, J, George, CM. Feasibility of contracting for medication therapy management services in a physician''s office. Am J Health Syst Pharm, 66 (15), 1390-3, 2009.
9. Guirguis, AB, Zingone, MM. Medication therapy management and cost-related medication nonadherence. JAMA, 300 (10), 1130; author reply 1130-1, 2008.
10. Fulco, PP, Zingone, MM, Higginson, RT. Possible antiretroviral therapy-warfarin drug interaction. Pharmacotherapy, 28 (7), 945-9, 2008.
11. Zingone, MM, Malcolm, KE, McCormick, SW, Bledsoe, KR. Analysis of pharmacist charges for medication therapy management services in an outpatient setting. Am J Health Syst Pharm, 64 (17), 1827-31, 2007.